Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 28, 2015 12:09 AM ET

Health Care Technology

Company Overview of iRhythm Technologies, Inc.

Company Overview

iRhythm Technologies, Inc., a digital healthcare company, develops and commercializes FDA-cleared solutions that integrate biosensor technology, patient data, analytics, and medical expertise for institutions and patients in the United States and internationally. It offers ZIO Service, which provides a proven approach to long-term continuous monitoring that enables diagnosis earlier in the clinical pathway to improve patient outcomes and reduce healthcare costs. The company was founded in 2006 and is headquartered in San Francisco, California with locations in Lincolnshire, Illinois; Houston, Texas; and Huntington Beach, California.

650 Townsend Street

Suite 380

San Francisco, CA 94103

United States

Founded in 2006

Phone:

415-632-5700

Fax:

415-632-5701

Key Executives for iRhythm Technologies, Inc.

Chief Executive Officer, President and Director
Age: 57
Chief Financial Officer
Chief Clinical Officer and Executive Vice President
Executive Vice President of Corporate Sales & Payer Relations
Executive Vice President of Global Strategy and Corporate Development
Compensation as of Fiscal Year 2014.

iRhythm Technologies, Inc. Key Developments

iRhythm Technologies, Inc. Appoints Derrick Sung as Executive Vice President of Global Strategy and Corporate Development

iRhythm Technologies, Inc. announced the appointment of Derrick Sung, Ph.D. to the executive management team as executive vice president of global strategy and corporate development, effective May 1, 2015. Dr. Sung will be responsible for driving new revenue opportunities by monetizing iRhythm's rapidly growing proprietary algorithms and patient database in mobile applications, analytics for consumer health monitoring and biomarker discovery. He will also drive global market development efforts for iRhythm's ZIO® Service, an FDA-cleared, outpatient cardiac monitor designed to improve patient compliance while maximizing diagnostic yield. Prior to joining iRhythm, Dr. Sung was a senior equity research analyst at Sanford C. Bernstein & Company covering medical devices at leading cardiovascular and orthopedic companies including Johnson & Johnson, St. Jude, Abbott, Medtronic and Boston Scientific. Previously, he served as the director of marketing and business development at Boston Scientific Neuromodulation where he led the commercialization of neurostimulation devices to treat a variety of therapeutic areas. Earlier, he spent four years at The Boston Consulting Group leading healthcare consulting projects ranging from licensing strategies, post-merger integrations, product development strategies, and operational effectiveness programs for biopharma and medical device companies. He began his career in the medical device field as a R&D engineer designing heart catheters for Guidant Corporation.

Banner Health to Offer iRhythm Technologies, Inc.'s ZIO Service for Continuous Cardiac Monitoring

iRhythm Technologies, Inc. announced that Banner Health will now be offering iRhythm's ZIO Service to patients in need of long-term continuous cardiac monitoring. The ZIO Service has the ability to record, store and analyze every heartbeat for up to 14 days and provides diagnostic support services that deliver comprehensive, actionable information to physicians. The ZIO Service will be available to the entire Banner Health system in 28 hospitals in seven states, including Alaska, Arizona, California, Colorado, Nebraska, Nevada and Wyoming. The ZIO Service is the first long-term continuous monitoring service that is FDA-cleared and supported by extensive clinical data with peer-reviewed publications. The ZIO Service has been clinically proven to enhance clinical decision making and potential lower healthcare costs. Since its commercial launch in 2011, it has been used with over 300,000 patients at nearly 1,000 institutions in the U.S.

iRhythm Technologies, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 02:30 PM

iRhythm Technologies, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 02:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Kevin M. King, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
South Doctors, Inc. United States
DataCeutics, Inc. United States
HealthCare Simulations, LLC United States
HealthCare MarketMaker, Inc. United States
Data Systems Group United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact iRhythm Technologies, Inc., please visit www.irhythmtech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.